Corbus Pharmaceuticals Holdings Inc (NAS:CRBP)
$ 44.14 1.15 (2.68%) Market Cap: 471.71 Mil Enterprise Value: 356.61 Mil PE Ratio: 0 PB Ratio: 4.78 GF Score: 35/100

Q4 2020 Corbus Pharmaceuticals Holdings Inc Earnings Call Transcript

Mar 15, 2021 / 12:30PM GMT
Release Date Price: $68.1 (-2.58%)
Operator

Hello, and welcome to the Corbus Pharmaceuticals Fourth Quarter and Year-End 2020 Earnings Conference Call. (Operator Instructions)

Note that this conference call is being recorded at the company's request and will be made available on the company's website following the end of the call.

I would now like to turn the conference over to your host, Ted Jenkins, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir.

Ted Jenkins
Corbus Pharmaceuticals Holdings, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator, and good morning, everyone. Thank you for joining us today. At this time, I'd like to remind our listeners that remarks made during this call may state management's intentions, hopes, beliefs, expectations or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are based on Corbus'

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot